Literature DB >> 16256412

Oral malignant neoplasia: a survey of 428 cases in two Zimbabwean hospitals.

M M Chidzonga1.   

Abstract

A review of oral malignant neoplasms biopsies accessioned in the pathology services of Harare Central Hospital and Parirenyatwa Hospital, Harare, Zimbabwe, during the 10year period January 1982 to December 1991 was carried out. Clinical records of 428 patients with histologically diagnosed oral malignant neoplasms by ICD-O type and site (COO.O-CO6.9) were retrieved and analyzed for gender, age, history of tobacco and alcohol usage, neoplastic type and histologic differentiation of squamous cell carcinoma (8000/3). Oral malignant neoplasms constituted 24.8% (n = 428) of the 1723 biopsies accessioned in the department during this period. There was a male to female ratio of 1.9:1, with lesions being most common in the 41-60 year age group. Squamous cell carcinoma, (8070/3) 73.1%, was the predominant oral malignancy most common in the 61-70 year age group with 21.1% on the mandibular gingivae (CO3.1), 20.5% on the tongue (CO1.9-CO2.9), 18.5% on the floor of the mouth (CO4.9) and 10.5% each on the maxillary gingivae (CO3.O) and buccal mucosa (CO6.O). The hard palate (CO5.9) had 9% of the lesions. Lip malignancy (COO-COO.9 and C44.0), inclusive of mucosa of lip, vermilion and skin, constituted 3.3% and minor salivary gland (CO6.9) malignancy (M-8940/3) 4.9%. The remaining oral malignancies, 11%, included Burkitt's lymphoma (M-9687/3) 4.7%; Kaposi's sarcoma (M-9140/3) 3.7%; osteosarcoma (M-9180/3) 2.6% and malignant melanoma (M-8720/3) 1.9%. Fourty five percent of the patients admitted tobacco and alcohol consumption, of whom 95% were males. Oral malignant neoplasms were more common in males than females and occurred in a relatively young age group. Well-differentiated squamous cell carcinoma (M-8070/31) was the most common oral malignant neoplasm and was most frequently found on the mandibular gingivae (CO3.1), tongue (CO1.9-CO2.9) and floor of the mouth (CO4.9). The lip (COO-COO.9) was least affected with a high palatal (CO5.9) involvement.

Entities:  

Mesh:

Year:  2005        PMID: 16256412     DOI: 10.1016/j.oraloncology.2005.07.003

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  17 in total

1.  GLI-mediated Keratin 17 expression promotes tumor cell growth through the anti-apoptotic function in oral squamous cell carcinomas.

Authors:  Yurie Mikami; Shinsuke Fujii; Kengo Nagata; Hiroko Wada; Kana Hasegawa; Misaki Abe; Reiko U Yoshimoto; Shintaro Kawano; Seiji Nakamura; Tamotsu Kiyoshima
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-24       Impact factor: 4.553

Review 2.  Review: Head and neck squamous cell carcinoma in sub-Saharan Africa.

Authors:  C E Faggons; C Mabedi; C G Shores; S Gopal
Journal:  Malawi Med J       Date:  2015-09       Impact factor: 0.875

3.  [Prognostic factors for oral squamous cell carcinoma].

Authors:  A W Eckert; M H W Lautner; R Dempf; J Schubert; U Bilkenroth
Journal:  Chirurg       Date:  2009-02       Impact factor: 0.955

4.  Comparative evaluation of serum alpha-1antitrypsin levels in patients with oral squamous cell carcinoma and in subjects with tobacco habit without carcinoma.

Authors:  Upasana S Ahuja; Nidhi Puri; Anjana Bagewadi; Vaishali Keluskar; Anshuman Ahuja; Harkanwal P Singh
Journal:  J Family Med Prim Care       Date:  2019-11-15

5.  Epidemiology of the sarcomas of the jaws in a Peruvian population.

Authors:  J-O Guevara-Canales; S-J Sacsaquispe-Contreras; R Morales-Vadillo; J Sánchez-Lihón
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-03-01

6.  Analysis of 46 cases of malignant jaw tumours in Calabar, Nigeria.

Authors:  Godwin Obi Bassey; Otasowie Daniel Osunde; Charles Ezechukwu Anyanechi
Journal:  Niger Med J       Date:  2015 Jul-Aug

7.  Analysis of THREE-year prevalence of oral cavity, neck and head tumors - a retrospective single-centre study.

Authors:  Sinan Rusinovci; Xhevdet Aliu; Tomislav Jukić; David Štubljar; Naim Haliti
Journal:  Acta Clin Croat       Date:  2020-09       Impact factor: 0.932

8.  STAT3 signal transduction through interleukin-22 in oral squamous cell carcinoma.

Authors:  Lutfun Naher; Tamotsu Kiyoshima; Ieyoshi Kobayashi; Hiroko Wada; Kengo Nagata; Hiroaki Fujiwara; Yukiko F Ookuma; Satoru Ozeki; Seiji Nakamura; Hidetaka Sakai
Journal:  Int J Oncol       Date:  2012-08-21       Impact factor: 5.650

9.  Tumours and tumour-like lesions of the lower face at Korle Bu Teaching Hospital, Ghana--an eight year study.

Authors:  Grace E A Parkins; George Armah; Patrick Ampofo
Journal:  World J Surg Oncol       Date:  2007-05-07       Impact factor: 2.754

10.  Chemoresistance to concanamycin A1 in human oral squamous cell carcinoma is attenuated by an HDAC inhibitor partly via suppression of Bcl-2 expression.

Authors:  Tamotsu Kiyoshima; Hisato Yoshida; Hiroko Wada; Kengo Nagata; Hiroaki Fujiwara; Makiko Kihara; Kana Hasegawa; Hirotaka Someya; Hidetaka Sakai
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.